-
Mashup Score: 1IMPACT CKD: 10-year Outlook on Chronic Kidney Disease - 11 day(s) ago
Dr Jerome Rossert (Head of Clinical Renal, AstraZeneca) joins us to discuss the findings of IMPACT CKD, a modelling analysis study aiming to evaluate the potential impact of chronic kidney
Source: www.radcliffecardiology.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 0Electronic Health Record-Based Population Health Management Strategy May Improve CKD Care - 16 day(s) ago
Although the intervention did not reduce risk of CKD progression versus standard care, it addressed barriers to care and increased patients’ exposure to ACEi/ARBs.
Source: www.hcplive.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 0
Using the National Institutes of Health Toolbox Cognition Battery, results showed greater cognitive dysfunction across certain domains based on sex and CKD stage.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Electronic Health Record-Based Population Health Management Strategy May Improve CKD Care - 19 day(s) ago
Although the intervention did not reduce risk of CKD progression versus standard care, it addressed barriers to care and increased patients’ exposure to ACEi/ARBs.
Source: www.hcplive.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 2EnquĂŞte Bayer RS - 24 day(s) ago
Faites de votre collecte de données une formidable expérience avec Typeform. Créez de superbes formulaires en ligne, des sondages, des quiz, et bien plus encore. Testez-le GRATUITEMENT.
Source: lenmedical.typeform.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 7Risks and Benefits of Different Dietary Patterns in CKD - 2 month(s) ago
Food has the potential to cause and exacerbate many lifestyle diseases. Or it can be used to prevent and treat illnesses like primary hypertension, the metabolic syndrome, and insulin resistance. In parallel, there is also a growing body of evidence of the role of diet in the treatment of kidney disease and its ensuing complications. Popular diets for this purpose have included low-carbohydrate diets, including the ketogenic diet, and higher carbohydrate diets like Mediterranean diets and other plant-based dietary patterns.
Source: www.ajkd.orgCategories: General Medicine News, NephrologyTweet
-
Mashup Score: 4Screening, identifying, and treating chronic kidney disease: why, who, when, how, and what? - BMC Nephrology - 2 month(s) ago
1 in 7 American adults have chronic kidney disease (CKD); a disease that increases risk for CKD progression, cardiovascular events, and mortality. Currently, the US Preventative Services Task Force does not have a screening recommendation, though evidence suggests that screening can prevent progression and is cost-effective. Populations at risk for CKD, such as those with hypertension, diabetes, and age greater than 50 years should be targeted for screening. CKD is diagnosed and risk stratified with estimated glomerular filtration rate utilizing serum creatinine and measuring urine albumin-to-creatinine ratio. Once identified, CKD is staged according to C-G-A classification, and managed with lifestyle modification, interdisciplinary care and the recently expanding repertoire of pharmacotherapy which includes angiotensin converting enzyme inhibitors or angiotensin-II receptor blockers, sodium-glucose-cotransporter-2 inhibitors, and mineralocorticorticoid receptor antagonists. In this pa
Source: bmcnephrol.biomedcentral.comCategories: General Medicine News, NephrologyTweet
-
Mashup Score: 1Association of Longitudinal B-Type Natriuretic Peptide Monitoring With Kidney Failure in Patients With CKD: AÂ Cohort Study - 3 month(s) ago
Both hypervolemia and hypovolemia are associated with chronic kidney disease (CKD) progression. Although longitudinal monitoring of B-type natriuretic peptide (BNP) may aid physicians’ decision making about the optimization of volume status, its clinical benefit remains uncertain in CKD. This study assessed the association between BNP monitoring and the risk of incident kidney replacement therapy (KRT).
Source: www.ajkd.orgCategories: General Medicine News, NephrologyTweet
-
Mashup Score: 4Screening, identifying, and treating chronic kidney disease: why, who, when, how, and what? - BMC Nephrology - 3 month(s) ago
1 in 7 American adults have chronic kidney disease (CKD); a disease that increases risk for CKD progression, cardiovascular events, and mortality. Currently, the US Preventative Services Task Force does not have a screening recommendation, though evidence suggests that screening can prevent progression and is cost-effective. Populations at risk for CKD, such as those with hypertension, diabetes, and age greater than 50 years should be targeted for screening. CKD is diagnosed and risk stratified with estimated glomerular filtration rate utilizing serum creatinine and measuring urine albumin-to-creatinine ratio. Once identified, CKD is staged according to C-G-A classification, and managed with lifestyle modification, interdisciplinary care and the recently expanding repertoire of pharmacotherapy which includes angiotensin converting enzyme inhibitors or angiotensin-II receptor blockers, sodium-glucose-cotransporter-2 inhibitors, and mineralocorticorticoid receptor antagonists. In this pa
Source: bmcnephrol.biomedcentral.comCategories: General Medicine News, NephrologyTweet
-
Mashup Score: 7FDA Adds Boxed Warning to Denosumab for Increased Risk of Hypocalcemia in Patients With CKD - 3 month(s) ago
According to the FDA review, patients with CKD receiving denosumab for osteoporosis who are on dialysis or have CKD-MBD are at the highest risk of severe hypocalcemia.
Source: www.pharmacytimes.comCategories: General Medicine News, General Journals & SocietTweet
🌟New Interview 🎙️Dr Jerome Rossert discusses findings of the IMPACT CKD study on the potential impact of #CKD over the next decade. 📊125m people estimated to suffer from advanced CKD by 2032 📊$186bn estimated toll of renal replacement therapy 📽️👉 https://t.co/gN56IuNEyh https://t.co/3ZHdhe5tU3